IMPI | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

780 results for “IMPI”

Trials

View all 680 →

IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion

2,176 participants · First posted Feb 4, 2016

High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis

52 participants · First posted Aug 21, 2020

Dual-target Ultrasound Guided Corticosteroid Injection for Shoulder Impingement Syndrome

210 participants · First posted Jan 7, 2020

Drugs

View all 78 →

Ompi-to

ISPI-55

IMPT-514

Organizations

Impinj

United States

Empi, Inc.

United States

INSTITUTO DE MEDICINA INTEGRAL PROFESSOR FERNANDO FIGUEIRA - IMIP

Brazil

News

View all 19 →

Mexico's Patent Office Includes Second-Use Pharmaceutical Patents in Linkage Gazette for First Time

Mexico Amends Health Supplies Regulations: Patent Term Compensation and Data Exclusivity Now in Effect

Mexico Cuts Clinical Trial Approval Times From 120 to 30 Days, Unlocking US$643 Million in Pharma Investment

Page 1 of 78